Hypersensitivity and Application site scab

Summary:

Application site scab is found among people with Hypersensitivity, especially for people who are female, 60+ old.

The study analyzes which people have Application site scab with Hypersensitivity. It is created by eHealthMe based on reports of 15 people who have Hypersensitivity from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,750 drugs and 2,915 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

What is Application site scab?

Application site scab (hard coating on the skin formed at application site) is found to be associated with 97 drugs and 283 conditions by eHealthMe. Check the latest studies of Application site scab.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

15 people who have Hypersensitivity and Application Site Scab are studied.

Would you have Application site scab when you have Hypersensitivity?

Gender of people who have Hypersensitivity and experienced Application Site Scab *:

female: 71.43 %
male: 28.57 %

Age of people who have Hypersensitivity and experienced Application Site Scab *:

Common co-existing conditions for these people *:

High Blood Pressure: 6 people, 40.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 26.67%
Essential Tremor: 3 people, 20.00%
Swelling: 3 people, 20.00%
Pain: 3 people, 20.00%
Arterial Disorder: 3 people, 20.00%
Gastric Disorder (disease of stomach): 3 people, 20.00%
Bladder Disorder: 3 people, 20.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 3 people, 20.00%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 20.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Application Site Erythema (redness of the skin at application site): 11 people, 73.33%
Application Site Pruritus (application site severe itching of the skin): 9 people, 60.00%
Application Site Burn: 4 people, 26.67%
Application Site Irritation: 4 people, 26.67%
Application Site Vesicles (small bubble within a cell at application site): 4 people, 26.67%
Application Site Exfoliation (application site removal of the oldest dead skin cells on the skin's outermost surface): 3 people, 20.00%
Application Site Reaction: 3 people, 20.00%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 2 people, 13.33%
Application Site Discoloration: 2 people, 13.33%
Application Site Pain: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Application site scab?

- Check whether Application site scab is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Application site scab and Hypersensitivity, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.